direct meds tirzepatide reviews Henry Direct Meds

doi:10.1021/acs.oprd.1c00108

Wegovy is a glucagon-like peptide 1 receptor agonist (GLP1-RA) injectable therapy approved by the Federal Drug Administration (FDA) for chronic weight management in adults who are obese or overweight with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol

Select lower-sodium, nitrate-free versions to reduce salt retention while keeping hunger controlled

M., Campbell, J

Conclusions The results support that tirzepatide leads to substantial weight reduction and constitutes a valuable therapeutic option for weight management, despite an increase in gastrointestinal symptoms